K‐S Yu

Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance

K‐H Shin, Min‐Ho Choi, K S Lim et al. · Clinical Pharmacology & Therapeutics · 2013 · 104 citations

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetic and Pharmacodynamic Interaction of Lorazepam and Valproic Acid in Relation to UGT2B7 Genetic Polymorphism in Healthy Subjects

Jae‐Yong Chung, K‐S Yu, J-R Kim et al. · Clinical Pharmacology & Therapeutics · 2007 · 89 citations

Medicine, Pharmacokinetics, Pharmacology +15

Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal‐weight adolescents

K. Cho, Jin Soo Moon, Jae‐Heon Kang et al. · Pediatric Obesity · 2016 · 72 citations

Life Sciences, Nutrition, Mass Spectrometric Analysis +16

Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects

Seung Hoo Lee, B.-H. Kim, Kyoung Soo Lim et al. · Journal of Clinical Pharmacy and Therapeutics · 2012 · 49 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +11

Modeling of Brain D2 Receptor Occupancy-Plasma Concentration Relationships with a Novel Antipsychotic, YKP1358, Using Serial PET Scans in Healthy Volunteers

Kyoung Soo Lim, Jun Soo Kwon, I‐J Jang et al. · Clinical Pharmacology & Therapeutics · 2007 · 35 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16